中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对于川崎病IVIG敏感性的预测价值

袁迎第, 孙军, 李鹏飞, 魏春雷, 于艳辉

中国当代儿科杂志 ›› 2017, Vol. 19 ›› Issue (4) : 410-413.

PDF(1288 KB)
HTML
PDF(1288 KB)
HTML
中国当代儿科杂志 ›› 2017, Vol. 19 ›› Issue (4) : 410-413. DOI: 10.7499/j.issn.1008-8830.2017.04.010
论著·临床研究

中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对于川崎病IVIG敏感性的预测价值

  • 袁迎第, 孙军, 李鹏飞, 魏春雷, 于艳辉
作者信息 +

Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease

  • YUAN Ying-Di, SUN Jun, LI Peng-Fei, WEI Chun-Lei, YU Yan-Hui
Author information +
文章历史 +

摘要

目的 分析中性粒细胞与淋巴细胞比值(NLR)及血小板与淋巴细胞比值(PLR)对川崎病(KD)免疫球蛋白(IVIG)敏感性的预测作用。方法 采用回顾性队列研究,以404例初诊川崎病患者为研究对象,收集IVIG治疗前后的血常规、NLR和PLR值,通过ROC曲线确定NLR和PLR在预测川崎病IVIG不敏感的最佳cut-off值;用logistic回归确定IVIG不敏感的独立预测因素。结果 404例川崎病患者中31例IVIG不敏感。与IVIG敏感组相比,IVIG不敏感组的冠状动脉扩张发生率明显增高(P < 0.01);启用IVIG时的病程较短(P < 0.05);IVIG治疗前后的NLR、PLR水平以及CRP均较高(P < 0.05)。IVIG治疗前、后的NLR和PLR对川崎病IVIG不敏感最佳预测值分别为4.36、162和1.45、196。多元回归分析显示IVIG治疗前的病程、CRP,以及IVIG治疗前后的NLR和PLR是IVIG不敏感的独立预测因素。结论 NLR和PLR可能作为川崎病患者丙球不敏感的预测指标。

Abstract

Objective To study the values of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in predicting the sensitivity to intravenous immunoglobulin (IVIG) in Kawasaki disease (KD). Methods A retrospective cohort study was conducted in 404 children with newly diagnosed KD. The data on routine blood tests, NLR, and PLR were collected before and after IVIG treatment. The receiver operating characteristic (ROC) curve was used to determine the cut-off values of NLR and PLR in predicting the insensitivity to IVIG. A logistic regression analysis was used to identify independent predictive factors for insensitivity to IVIG. Results Of all patients, 31 were insensitive to IVIG. Compared with the IVIG sensitivity group, the IVIG insensitivity group had a significantly higher incidence rate of coronary artery ectasia (P < 0.01), a shorter course of disease when IVIG therapy was initiated (P < 0.05), and significantly higher NLR, PLR, and C-reactive protein (CRP) level before and after treatment (P < 0.05). The optimal cut-off values for NLR and PLR to predict IVIG insensitivity were 4.36 and 162 before IVIG treatment and 1.45 and 196 after treatment. The multivariate regression analysis showed that the course of disease before IVIG treatment, CRP before IVIG treatment, and NLR and PLR before and after IVIG treatment were independent predictive factors for IVIG insensitivity. Conclusions NLR and PLR can be used to predict IVIG insensitivity in children with KD.

关键词

川崎病 / 冠状动脉病变 / 白细胞 / 静注免疫球蛋白 / 儿童

Key words

Kawasaki disease / Coronary artery disease / Leukocyte / Intravenous immunoglobulin / Child

引用本文

导出引用
袁迎第, 孙军, 李鹏飞, 魏春雷, 于艳辉. 中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对于川崎病IVIG敏感性的预测价值[J]. 中国当代儿科杂志. 2017, 19(4): 410-413 https://doi.org/10.7499/j.issn.1008-8830.2017.04.010
YUAN Ying-Di, SUN Jun, LI Peng-Fei, WEI Chun-Lei, YU Yan-Hui. Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease[J]. Chinese Journal of Contemporary Pediatrics. 2017, 19(4): 410-413 https://doi.org/10.7499/j.issn.1008-8830.2017.04.010

参考文献

[1] McCrindle BW, Li JS, Minich LL, et al. Coronary artery involvement in children with Kawasaki disease:risk factors from analysis of serial normalized measurements[J]. Circulation, 2007, 116(2):174-179.
[2] Ha KS, Lee J, Jang GY, et al. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease[J]. Am J Cardiol, 2015, 116(2):301-306.
[3] Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease:a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the Young, American Heart Association[J]. Circulation, 2004, 110(17):2747-2771.
[4] Hwang SY, Shin TG, Jo IJ, et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients[J]. Am J Emerg Med, 2017, 35(2):234-239.
[5] Azab B, Zaher M, Weiserbs KF, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short-and long-term mortality after non-ST-elevation myocardial infarction[J]. Am J Cardiol, 2010, 106(4):470-476.
[6] Park JJ, Jang HJ, Oh IY, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Am J Cardiol, 2013, 111(5):636-642.
[7] Acet H, Ertas F, Ak?l MA, et al. Relationship between hematologic indices and global registry of acute coronary events risk score in patients with ST-segment elevation myocardial infarction[J]. Clin Appl Thromb Hemost, 2016, 22(1):60-68.
[8] Lian L, Xia YY, Zhou C, et al. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer[J]. Cancer Biomark, 2015, 15(6):899-907.
[9] Çiçek G, Aç?kgoz SK, Bozbay M, et al. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Angiology, 2015, 66(5):441-447.
[10] Cummings M, Merone L, Keeble C, et al. Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival[J]. Br J Cancer, 2015, 113(2):311-320.
[11] Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease[J]. Circulation, 2006, 113(22):2606-2612.
[12] Kim T, Choi W, Woo CW, et al. Predictive risk factors for coronary artery abnormalities in Kawasaki disease[J]. Eur J Pediatr, 2007, 166(5):421-425.
[13] Kawamura Y, Takeshita S, Kanai T, et al. The combined usefulness of the neutrophil-to-lymphocyte and platelet-tolymphocyte ratios in predicting intravenous immunoglobulin resistance with Kawasaki disease[J]. J Pediatr, 2016, 178:281-284.e1.
[14] Yim D, Curtis N, Cheung M, et al. An update on Kawasaki disease II:clinical features, diagnosis, treatment and outcomes[J]. J Paediatr Child Health, 2013, 49(8):614-623.
[15] 《中华儿科杂志》编辑委员会, 中华医学会儿科学分会心血管学组, 中华医学会儿科学分会免疫学组. 川崎病专题讨论会纪要[J]. 中华儿科杂志, 2007, 45(11):826-830.
[16] Research Committee of Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease[S]. Tokyo, Japan:Ministry of Health and Welfare, 1984.
[17] Sato S, Kawashima H, Kashiwagi Y, et al. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients[J]. Int J Rheum Dis, 2013, 16(2):168-172.
[18] Daniels LB, Tjajadi MS, Walford HH, et al. Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia[J]. Circulation, 2012, 125(20):2447-2453.
[19] Adachi S, Sakaguchi H, Kuwahara T, et al. High regression rate of coronary aneurysms developed in patients with immune globulin-resistant Kawasaki disease treated with steroid pulse therapy[J]. Tohoku J Exp Med, 2010, 220(4):285-290.


PDF(1288 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/